Company intelligence / Profile preview

TRICAPITAL Angels Ltd

United Kingdom

Ownership: Private
Development stage: Other

Overview

TRICAPITAL Angels is an active investor in Scottish deep-tech and biotech startups, including ScreenIn3D (lab-on-a-chip for cancer drug testing), OGI Bio (microbial culturing), Beta Bugs (insect genetics), Carcinotech (3D-printed mini-tumours), and others in their portfolio. They led investments totaling millions in 2024, leveraging high-net-worth individuals to support innovative companies in biotech, AI, and renewables.

Industry: Investors

Beyond the preview

Go deeper on TRICAPITAL Angels Ltd.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TRICAPITAL Angels Ltd.

Explore the full profile